Announce Date | 05/28/2025 |
EPS Normalized Actual | $0.71 (Miss by $-0.093) |
EPS GAAP Actual | $0.71 (Miss by $-0.093) |
Revenue Actual | $13.22B |
Revenue Surprise | Beat by $13220M |
Announce Date | 07/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.91055 |
EPS GAAP Estimate | $0.91055 |
Revenue Estimate | $13.78594697B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2027 | 3.44 | 7.51 | 3.37611 | 3.49993 | 1 |
Oct 2026 | 3.16 | 8.18 | 3.16 | 3.16 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.43 | 0.43 | 13.22B | 3.47% | 13220M |
FQ1 2025 (Jan 2025) | 0.6 | 0.6 | 13.504B | 2.36% | 13504M |
FQ4 2024 (Oct 2024) | 0.94 | 0.94 | 14.055B | 1.69% | 14055M |
FQ3 2024 (Jul 2024) | 0.65 | 0.65 | 13.519B | 2.39% | 13519M |
FQ2 2024 (Apr 2024) | 0.62 | 0.62 | 12.761B | -1.19% | 12761M |
FQ1 2024 (Jan 2024) | 0.62 | 0.62 | 13.185B | -4.88% | 13185M |
FQ4 2023 (Oct 2023) | 0.98 | 0.98 | 13.817B | -7.12% | 13817M |
FQ3 2023 (Jul 2023) | 0.77 | 0.77 | 13.196B | -11.12% | 13196M |
FQ4 Announce Date
07/30/2025 (Pre-Market)
Consensus EPS Estimates
0.91055
Consensus Revenue Estimates
13.78594697B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.09304 | -- | 1.0796 | 1.10818 | 9 |
FQ3 2027 (Jul 2027) | 0.99016 | -- | 0.97799 | 1.00388 | 6 |
FQ2 2027 (Apr 2027) | 0.98821 | -- | 0.97857 | 0.9959 | 4 |
FQ1 2027 (Jan 2027) | 0.84251 | -- | 0.81443 | 0.85644 | 9 |
FQ4 2026 (Oct 2026) | 1.0082 | -- | 0.98734 | 1.03277 | 5 |
FQ3 2026 (Jul 2026) | 0.9102 | -- | 0.89137 | 0.93238 | 2 |
FQ2 2026 (Apr 2026) | 0.94052 | 54.28 | 0.92106 | 0.96344 | 2 |
FQ1 2026 (Jan 2026) | 0.88931 | 32.53 | 0.86879 | 0.91409 | 2 |
FQ4 2025 (Oct 2025) | 0.97169 | 3.26 | 0.95158 | 0.99537 | 3 |
FQ3 2025 (Jul 2025) | 0.91055 | 28.61 | 0.89171 | 0.93274 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 15.3B | -- | 15.16B | 15.46B | 6 |
FQ3 2027 (Jul 2027) | 14.53B | -- | 14.39B | 14.68B | 4 |
FQ2 2027 (Apr 2027) | 13.29B | -- | 13.19B | 13.37B | 2 |
FQ1 2027 (Jan 2027) | 14.28B | -- | 13.91B | 14.46B | 5 |
FQ4 2026 (Oct 2026) | 14.65B | -- | 14.42B | 14.93B | 3 |
FQ3 2026 (Jul 2026) | 13.76B | -- | 13.54B | 14.01B | 3 |
FQ2 2026 (Apr 2026) | 13.26B | 0.28 | 13.05B | 13.51B | 3 |
FQ1 2026 (Jan 2026) | 14.1B | 4.24 | 13.85B | 14.4B | 3 |
FQ4 2025 (Oct 2025) | 14.57B | 3.51 | 14.33B | 14.84B | 3 |
FQ3 2025 (Jul 2025) | 13.79B | 1.94 | 13.57B | 14.04B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.43 | 0.43 | 100% | |
FQ1 2025 (Jan 2025) | 0.6 | 0.6 | 100% | |
FQ4 2024 (Oct 2024) | 0.94 | 0.94 | 100% | |
FQ3 2024 (Jul 2024) | 0.65 | 0.65 | 100% | |
FQ2 2024 (Apr 2024) | 0.62 | 0.62 | 100% | |
FQ1 2024 (Jan 2024) | 0.62 | 0.62 | 100% | |
FQ4 2023 (Oct 2023) | 0.98 | 0.98 | 100% | |
FQ3 2023 (Jul 2023) | 0.77 | 0.77 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $0B | $13.22B | $13220M | 100% |
FQ1 2025 (Jan 2025) | $0B | $13.5B | $13504M | 100% |
FQ4 2024 (Oct 2024) | $0B | $14.06B | $14055M | 100% |
FQ3 2024 (Jul 2024) | $0B | $13.52B | $13519M | 100% |
FQ2 2024 (Apr 2024) | $0B | $12.76B | $12761M | 100% |
FQ1 2024 (Jan 2024) | $0B | $13.19B | $13185M | 100% |
FQ4 2023 (Oct 2023) | $0B | $13.82B | $13817M | 100% |
FQ3 2023 (Jul 2023) | $0B | $13.2B | $13196M | 100% |